JP
LOXO

John Paulson’s Loxo Oncology, Inc LOXO Stock Holding History

John Paulson’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,800
Closed -$2.1M – 61
2017
Q3 		$2.1M Sell
22,800
-664,093
-97% -$51.6M 0.04% 52
2017
Q2 		$55.1M Sell
686,893
-125,607
-15% -$6.96M 0.74% 30
2017
Q1 		$34.2M Sell
812,500
-16,141
-2% -$665K 0.45% 35
2016
Q4 		$26.6M Buy
828,641
+91,700
+12% +$2.35M 0.34% 43
2016
Q3 		$19.3M Buy
736,941
+486,600
+194% +$12.7M 0.21% 47
2016
Q2 		$5.8M Buy
250,341
+25,000
+11% +$622K 0.06% 63
2016
Q1 		$6.16M Buy
225,341
+143,162
+174% +$3M 0.05% 65
2015
Q4 		$2.34M Buy
+82,179
New +$2.21M 0.01% 67

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

John Paulson's LOXO Position: Q4 2017 in Review

John Paulson sold out of Loxo Oncology, Inc (LOXO) in Q4 2017, closing a stake of 22,800 shares — an estimated $2.1M sold.

John Paulson first reported a position in LOXO in Q4 2015 and held it in 8 quarters. The position peaked at $55.1M in Q2 2017. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

  • John Paulson reported no remaining Loxo Oncology, Inc position as of Q4 2017 after selling out during the quarter.
  • John Paulson sold 22,800 Loxo Oncology, Inc shares in Q4 2017, an estimated $2.1M.
  • John Paulson first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 8 quarters.
  • John Paulson's Loxo Oncology, Inc position peaked at $55.1M in Q2 2017.
  • 141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on Paulson & Co's 13F filing for Q4 2017, filed 14 Feb 2018.